Trinity Biotech plc Announces Acquisition of Immco Diagnostics Inc.

Tuesday, 30 Jul 2013 09:38am EDT 

Trinity Biotech plc announced that the acquisition of Immco Diagnostics Inc. on July 26, 2013, for a consideration of $32.75 million. Immco is a diagnostic company specializing in the development, manufacture and sale of autoimmune test kits on a worldwide basis. This product line is complemented by specialized reference laboratory services in diagnostic immunology, pathology and immunogenetics, marketed to US-based reference laboratories and hospitals. 

Company Quote

-0.15 -0.89%
24 Nov 2014